COPD is a heterogenous condition, and accurate classification can help tailor therapies and improve patient outcomes. Quantitative computed tomography (QCT) techniques show promise in assessing COPD phenotypes. Companies have commercialized automated CT software packages, like Coreline Soft AVIEW, which are increasingly used in research and clinical settings. This article reviews key features of such platforms, their underlying technologies, and clinical applications. However, their full potential in diagnostic work-up and treatment planning remains to be explored.